Unknown PHASE2 INTERVENTIONAL 1-arm NCT03633864

Fecal Microbiota Transplantation for Refractory IgA Nephropathy

Fecal Microbiota Transplantation for Refractory IgA Nephropathy: a Prospective, Single-center, Cohort Study

Sponsor: Air Force Military Medical University, China

Interventions Fecal microbiota transplantation

Updated 5 times since 2018 Last updated: Aug 18, 2018 Started: Nov 22, 2017 Primary completion: Dec 31, 2020 Completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates IgA Nephropathy and is currently ongoing. Air Force Military Medical University, China leads this study, which shows 5 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Nov 2020 — Jan 2021 [monthly]

Recruiting PHASE2
Sep 2018 — Nov 2020 [monthly]

Recruiting PHASE2

First recorded

Nov 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Air Force Military Medical University, China

Data source: Air Force Military Medical University, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Xi'an, China